Revolade Tablets Specified Drug-use Survey

Clinical trial NCT06287268 · RECRUITING

Trial details

NCT number: NCT06287268
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Aplastic Anemia

Start date: 2024-07-17
Primary completion: 2028-10-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.